CJC-1295
ResearchA long-acting growth hormone releasing hormone analog, often paired with Ipamorelin.
Growth HormoneLongevity
Half Life
~6-8 days (with DAC)
Time to Results
4-8 weeks
Administration
Subcutaneous injection

๐พ Griffin's Research Scorecard
Research Strength
Human Data
Animal Data
Long-Term Data
Beginner Friendly
Storage Difficulty
Injection Frequency1-2x per week
Cost$$$

๐พ Griffin Says...
Almost always stacked with Ipamorelin in the literature -- the two hit different receptors and the effect is complementary.
Benefits
- Elevated baseline GH
- Improved sleep
- Recovery
Best For
- Recovery
- Body composition
- Sleep quality
Body Systems
Endocrine
How It Works
CJC-1295 is a GHRH analog engineered for extended plasma stability. Researchers pair it with ghrelin mimetics like Ipamorelin to produce sustained GH pulses.
Mechanisms of Action
- GHRH receptor agonism
Side Effects
| Effect | Frequency | Severity |
|---|---|---|
| Injection site itch | Occasional | Mild |
| Flushing | Rare | Mild |
Contraindications
Active malignancy; pituitary disorders.
Peptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.
Ready to calculate your dose? Use Griffin's Peptide Calculator ๐พ
Open Calculator